Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCδ promotes cellular survival and chemotherapeutic resistance

Cancer Research

Volumn 63, Issue 4, 2003, Pages 780-786

  Clark, Amy S ^a   West, Kip A ^a   Blumberg, Peter M ^a   Dennis, Phillip A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTINEOPLASTIC AGENT; CALPHOSTIN C; CHELERYTHRINE; CISPLATIN; DOCETAXEL; GEMCITABINE; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; ROTTLERIN; TRASTUZUMAB;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETOPHENONES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BENZOPYRANS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; ISOENZYMES; LUNG NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TRANSFECTION;

EID: 0037443030     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brognard, J., Clark, A. S., Ni, Y., and Dennis, P. A. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res., 61: 3986-3997, 2001.
2. Brognard, J., and Dennis, P. A. Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ., 9: 893-904, 2002.
3. Dutil, E. M., Toker, A., and Newton, A. C. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol., 8: 1366-1375, 1998.
4. Li, W., Zhang, J., Flechner, L., Hyun, T., Yam, A., Franke, T. F., and Pierce, J. H. Protein kinase C-α overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene, 18: 6564-6572, 1999.
5. Doornbos, R. P., Theelen, M., van der Hoeven, P. C., van Blitterswijk, W. J., Verkleij, A. J., and van Bergen en Henegouwen, P. M. Protein kinase Cζ is a negative regulator of protein kinase B activity. J. Biol. Chem., 274: 8589-8596, 1999.
6. Gschwendt, M. Protein kinase C δ Eur. J. Biochem., 259: 555-564, 1999.
7. Parekh, D., Ziegler, W., Yonezawa, K., Hara, K., and Parker, P. J. Mammalian TOR controls one of two kinase pathways acting upon nPKCδ and nPKCε. J. Biol. Chem., 274: 34758-34764, 1999.
8. 2. Proc. Natl. Acad. Sci. USA, 94: 11233-11237, 1997.
9. 3. J. Biol. Chem., 269: 32358-32367, 1994.
10. Konishi, H., Kuroda, S., and Kikkawa, U. The pleckstrin homology domain of RAC protein kinase associates with the regulatory domain of protein kinase C ζ. Biochem. Biophys. Res. Commun., 205: 1770-1775, 1994.
11. 2 and heat shock through distinct mechanisms dependent and independent of phosphatidylinositol 3-kinase. J. Biochem. (Tokyo), 126: 1136-1143, 1999.
12. Cragg, L. H., Andreeff, M., Feldman, E., Roberts, J., Murgo, A., Winning, M., Tombes, M. B., Roboz, G., Kramer, L., and Grant, S. Phase 1 trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-β-D-arabinofuranosylcytosine in patients with refractory acute leukemia. Clin. Cancer Res., 8: 2123-2133, 2002.
13. Clamp, A., and Jayson, G. C. The clinical development of the bryostatins. Anticancer Drugs, 13: 673-683, 2002.
14. Reddel, R. R., Ke, Y., Gerwin, B. I., McMenamin, M. G., Lechner, J. F., Su, R. T., Brash, D. E., Park, J. B., Rhim, J. S., and Harris, C. C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res., 48: 1904-1909, 1988.
15. Newton, A. C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev., 101: 2353-2364, 2001.
16. Hofmann, J. The potential for isoenzyme-selective modulation of protein kinase C. FASEB J., 11: 649-669, 1997.
17. Webb, B. L., Lindsay, M. A., Seybold, J., Brand, N. J., Yacoub, M. H., Haddad, E. B., Barnes, P. J., Adcock, I. M., and Giembycz, M. A. Identification of the protein kinase C isoenzymes in human lung and airways smooth muscle at the protein and mRNA level. Biochem. Pharmacol., 54: 199-205, 1997.
18. Basu, A., Weixel, K., and Saijo, N. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell Growth Differ., 7: 1507-1512, 1996.
19. Mao, M., Fang, X., Lu, Y., Lapushin, R., Bast, R. C., Jr., and Mills, G. B. Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells. Biochem. J., 352: 475-482, 2000.
20. Gokmen-Polar, Y., Murray, N. R., Velasco, M. A., Gatalica, Z., and Fields, A. P. Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res., 61: 1375-1381, 2001.
21. Weller, S. G., Klein, I. K., Penington, R. C., and Karnes, W. E., Jr. Distinct protein kinase C isozymes signal mitogenesis and apoptosis in human colon cancer cells. Gastroenterology, 117: 848-857, 1999.
22. Mandil, R., Ashkenazi, E., Blass, M., Kronfeld, I., Kazimirsky, G., Rosenthal, G., Umansky, F., Lorenzo, P. S., Blumberg, P. M., and Brodie, C. Protein kinase Cα and protein kinase Cδ play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res., 61: 4612-4619, 2001.
23. Sonnenburg, E. D., Gao, T., and Newton, A. C. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J. Biol. Chem., 276: 45289-45297, 2001.
24. Young, R. C., and DeVita, V. T. Cell cycle characteristics of human solid tumors in vivo. Cell Tissue Kinet., 3: 285-290, 1970.
25. Basu, A., Johnson, D. E., and Woolard, M. D. Potentiation of tumor necrosis factor-α-induced cell death by rottlerin through a cytochrome-c-independent pathway. Exp. Cell Res., 278: 209-214, 2002.
26. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 351: 95-105, 2000.
27. Zrachia, A., Dobroslav, M., Blass, M., Kazimirsky, G., Kronfeld, I., Blumberg, P. M., Kobiler, D., Lustig, S., and Brodie, C. Infection of glioma cells with Sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C δ. Implications for Sindbis virus-induced apoptosis. J. Biol. Chem., 277: 23693-23701, 2002.
28. Blass, M., Kronfeld, I., Kazimirsky, G., Blumberg, P. M., and Brodie, C. Tyrosine phosphorylation of protein kinase Cδ is essential for its apoptotic effect in response to etoposide. Mol. Cell. Biol., 22: 182-195, 2002.
29. Wert, M. M., and Palfrey, H. C. Divergence in the anti-apoptotic signaling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC 12 cells: rescue by bFGF involves protein kinase Cδ. Biochem. J., 352: 175-182, 2000.
30. Li, W., Jiang, Y. X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., Pierce, J. H., and Wang, L. H. Protein kinase C-δ is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol. Cell. Biol., 18: 5888-5898, 1998.
31. Li, W., Yu, J. C., Michieli, P., Beeler, J. F., Ellmore, N., Heidaran, M. A., and Pierce, J. H. Stimulation of the platelet-derived growth factor β receptor signaling pathway activates protein kinase C-δ. Mol. Cell. Biol., 14: 6727-6735, 1994.
32. Kiley, S. C., Clark, K. J., Duddy, S. K., Welch, D. R., and Jaken, S. Increased protein kinase C δ in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene, 18: 6748-6757, 1999.
33. Kiley, S. C., Clark, K. J., Goodnough, M., Welch, D. R., and Jaken, S. Protein kinase C δ involvement in mammary tumor cell metastasis. Cancer Res., 59: 3230-3238, 1999.
34. Sumitomo, M., Ohba, M., Asakuma, J., Asano, T., Kuroki, T., and Hayakawa, M. Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J. Clin. Investig., 109: 827-836, 2002.
35. Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., and Kufe, D. Mitochondrial translocation of protein kinase C δ in phorbol ester-induced cytochrome c release and apoptosis. J. Biol. Chem., 275: 21793-21796, 2000.
36. Lounsbury, K. M., Stem, M., Taatjes, D., Jaken, S., and Mossman, B. T. Increased localization and substrate activation of protein kinase Cδ in lung epithelial cells following exposure to asbestos. Am. J. Pathol., 160: 1991-2000, 2002.